Evidence map›Paper›PMID 31695705›Full record

ArticleFrontiers in immunology

Corrigendum: The TNF Paradox in Cancer Progression and Immunotherapy.

Anne Montfort, Céline Colacios, Thierry Levade, Nathalie Andrieu-Abadie, Nicolas Meyer, Bruno Ségui

Registry-linked trialAbstract readPublished Erratum
In one paragraph

Article in Frontiers in immunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05867004 (Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05867004 recruitingnot on this map

Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma

TypeobservationalSponsorInstitut Claudius RegaudRan2023 to 2026Enrolled100ConditionsMelanoma, Immune Defect, Tumor Skin
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Cervical Cytokine Profile in High-Grade Squamous Intraepithelial Lesions.Cytopathology : official journal of the British Society for Clinical Cytology · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Anne MontfortINSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Céline ColaciosINSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Thierry LevadeINSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Nathalie Andrieu-AbadieINSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Nicolas MeyerINSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Bruno SéguiINSERM UMR 1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.01818.].

Indexed as

CTLA-4immune escapemelanomaPD-1tumor necrosis factor (TNF)

Identifiers

PMID31695705
PMCPMC6817917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.